Indoco Remedies gains on receiving approval from UK-MHRA for Goa facility

12 May 2017 Evaluate

Indoco Remedies is currently trading at Rs. 226.30, up by 1.75 points or 0.78% from its previous closing of Rs. 224.55 on the BSE.

The scrip opened at Rs. 226.30 and has touched a high and low of Rs. 226.30 and Rs. 226.20 respectively. So far 180 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 360.35 on 07-Sep-2016 and a 52 week low of Rs. 209.00 on 03-Apr-2017.

Last one week high and low of the scrip stood at Rs. 250.70 and Rs. 220.00 respectively. The current market cap of the company is Rs. 2069.24 crore.

The promoters holding in the company stood at 59.11%, while institutions and non-institutions held 21.26% and 19.63% respectively.

Indoco Remedies has received approval from the Regulatory Body, UK-MHRA for its solid dosages manufacturing facility in Goa (Plant I). This approval is the outcome of the inspection conducted in December 2016.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

210.20 -4.75 (-2.21%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×